Beyond Big Tech, Agilent Is Making Moves

The market has rewarded a relatively small circle of mega-cap technology stocks in recent weeks, while opportunities showing comparable strength across the broader market have been harder to find. Against that backdrop, one healthcare name has been quietly building a case of its own, fueled by stronger-than-expected earnings, resilient biopharma demand, and optimism surrounding a recent AI-focused pathology software acquisition. Agilent Technologies (A) has advanced through a series of higher highs and higher lows, reached fresh 52-week highs, and recently cleared multi-year overhead resistance dating back to 2021 to enter new all-time-high territory. Adding to that breakout, our ProfitSurge Buy signal has triggered, with the 21-day exponential moving average crossing above the 63-day EMA while the stock trades above both, confirming that shorter-term momentum is strengthening relative to the intermediate-term trend.

📈 Is market leadership shifting again? Blane unpacks the latest moves in mega-cap tech and semiconductors—and the top opportunities he’s watching. 👉 Don’t miss the replay!

There are multiple ways to approach a breakout like this, from buying shares outright to using a slightly in-the-money call option to gain bullish exposure with less upfront capital than purchasing 100 shares. For traders comfortable with options, the call offers leveraged participation if A continues higher, although the entire premium is at risk and the option can lose value if the stock stalls or declines. For one currently available setup, if A were to rally 10% by expiration, the selected call could be positioned for an 83.2% profit potential based on current pricing and the stated scenario, though actual results depend on the option’s price behavior and the stock’s path.

One of the biggest challenges for traders is turning market analysis into a consistent, repeatable approach rather than chasing whatever happens to be moving that week. The Options For Income Newsletter helps bridge that gap with multiple actionable income-focused trade ideas each week, including the technical reasoning, complete trade details, and strategy insights behind each setup—all available with a first-month trial for just $1. Click here to start your trial and see how a more structured approach to options trading can help you evaluate your next opportunity.

Wishing You the Best in Investing Success,